Kerecis, the company pioneering the use of sustainably sourced
fish skin and fatty acids in cellular therapy and tissue
regeneration and protection, will present two symposiums and 27
abstracts on its intact medical fish skin at the European Wound
Management Association (EWMA) this week. The company will also host
a medical education event on the utilization of fish skin grafts on
Wednesday, May 1. Finally, Kerecis’ founder and CEO will summarize
the company’s journey at the EWMA Innovation Forum Thursday, May 2.
Kerecis will be exhibiting at booth Nr. G30 at EWMA, which takes
place in London from May 1 to May 3.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240501756159/en/
Fertram Sigurjonsson, founder and CEO of
the medical-fish-skin company Kerecis, will describe his
entrepreneurial journey at the European Wound Management
Association (EWMA) Innovation Forum Thursday, May 2, at 10 a.m.
Kerecis is the only approved manufacturer of medical devices
containing intact fish skin globally. (Photo: Business Wire)
"It is great to see all these abstracts being presented EWMA.
They represent the commitment of the medical community to
organically grow the body of clinical evidence supporting the
efficacy of the Kerecis fish skin," said Fertram Sigurjonsson.
"There is a lot of innovation taking place in the field of wound
and tissue damage. We look forward to participating in the EWMA
Innovation Forum to learn about the latest innovations."
Kerecis will be the subject of the following events at the
conference:
- Intact Fish Skin for Chronic Wound Care – Dr. John Lantis,
chair. Industry-supported symposium. Thursday, May 2, 4 to 5 p.m.
in the South Gallery Room 8-9-10
- Fish Skin for Wound Management: Are There Advantages? – Dr.
Franziska Remy-Wohlfender, chair. Thursday, May 2, 9:30 to 9:50
a.m. at the Veterinary Wound Healing Association side conference,
South Gallery Room 27-28
- Kerecis medical education event: Improving Outcomes with Fish
Skin Grafts in Orthopedic, General Surgery and Pediatric Wound Care
–Prof. Guido Ciprandi, Marcus Duda, MD, and Elsa Valsdóttir, MD.
Wednesday, May 1, 7 p.m. Please register at events@kerecis.com
- Overcoming the Hurdles from Idea to Market – G. Fertram
Sigurjonsson, EWMA Innovation Forum, Thursday, May 2, 10 a.m. at
the South Gallery Room 22. To request an invitation to this event,
please email innovation@ewma.org.
The following abstracts containing scientific and clinical
updates and trial results for the Kerecis fish skin:
EP144: Christoph Wallner, Sonja Schmidt, Jana
Holtermann, Marcus Lehnhardt, Enhancing Burn Wound Management: Fish
Skin Grafts Expedite Healing and Improve Outcomes
EP375: Richard Bruno, Association of
Hemoglobin A1c and Wound Healing with Application of Omega-3 Fatty
Acid Fish Skin
EP376: Richard Bruno, Utility of Fish
Xenograft in Diabetic Plantar Foot Ulcerations
EP296: Richard Bruno, Fish Skin Xenografts in
the Management of Gas Gangrene Foot Infections
EP054: Woo Jin Song, Revolutionizing
Hard-to-heal Wounds with Fish Skin Acellular Dermal Matrix:
Pioneering Excellence and Efficacy
EP267: Roxana Reyna, OP: Successful Use of
Decellularized Piscine Graft in a Pediatric Extensive Wound
Reconstruction
EP397: Peter Lovato, Non-Healing Diabetic
Plantar Hallux Wounds Healed with Distal Medial Partial Plantar
Fasciotomy and Fish Skin Grafting
EP065: Alexandra Savage, Phillip Smit, Marina
Carro, Mark Melendez, Innovative Solutions in Reconstructive
Surgery: A Case Series on Complex Back Closures Using Omega-3
EP008: Marcus Duda, A Novel Application of
Fish Skin Graft for Reinforcement of Transtibial Amputation
EP462: Eric Lullove, Use of a Fish Skin Graft
with Synthetic Covering in Lower Extremity Wounds: A Pilot Study of
Efficacy and Cost
EP067: Ryan O’Quinn, Healing of Difficult
Mohs Surgical Scalp Wounds with Exposed Bone Using Decellularized
Fish Skin Grafts
EP422: Rimvydas Statkus, Peter Lovato,
Patrick McEneaney, Kimberly Nolan, Successful Treatment of Complex
Lower Extremity Wounds with Subcutanceous Ossification in
Heinz-Lippmann Disease: Case Report
EP744: Savatore Pacella, Reinforcement of the
Superficial Musculoaponeurotic System (Smas) with Intact
Decellularized Fish Skin in Deep Plane Facelifting: a Novel Salvage
Technique
EP378: Peter Lovato, Rimvydas Statkus,
Patrick McEneaney, Use of Fish Skin Grafting in Diabetic Wounds
with Known Peripheral Arterial Disease
EP460: Rene Amaya, Novel Application of Fish
Skin Grafts in Neonatal Wounds
EP654: Shufen Neo, Enming Yong, Li Zhang,
Case Report: Achieving Filling of Hard-to-Heal Diabetic Foot Wound
Cavity with Physician-modified Cut-up Fish Skin Graft to Achieve
Good Wound-Bed Contact
EP745: Ashtyn Vogt, Elise Steinberger, Jeremy
Tan, Skin and Bone – Intact Fish Skin to Reconstruct Traumatic
Orbital Floor and Wall Defects
EP578: Elsa Valsdottir, Acellular Fish Skin
for Severe Hidradenitis Suppurativa
EP742: Rimvydas Statkus, Peter Lovato,
Patrick McEneaney, Kimberly Nolan, Hyperpigmentation of Legs and
Feet after Use of Minocycline for a Wound Infection
EP739: Rimvydas Statkus, Patrick McEneaney,
Peter Lovato, Kimberly Nolan, Successful Healing of Multiple
Fasciotomy Wounds Secondary to Acute Compartment Syndrome with the
Use of Skin Substitutes and Negative Pressure Wound Therapy
(NPWT).
EP738: Rimvydas Statkus, Patrick McEneaney,
Peter Lovato, Kimberly Nolan, Surgical Applications of External
Fixator, Negative Pressure Wound Therapy (NPWT) and Application of
Skin Substitutes for Complex Lower Extremity Wounds: Multiple Case
Report
EP737: Rimvydas Statkus, Patrick McEneaney,
Peter Lovato, Kimberly Nolan, Complex Lower-Extremity Trauma Wounds
Successfully Treated with Surgery, Application of Skin Substitutes
and Negative Pressure Wound Therapy (NPWT).
EP334: Kirsten Smith, Fish Skin Graft for
Closure of Complex Stage 4 Pressure Wounds of Trunk in
Non-Operative Patients in the Outpatient Setting
About Kerecis
Kerecis develops products from fish skin and fatty acids for
cellular therapy, tissue regeneration and protection. When grafted
onto damaged human tissue or implanted, the patented material
supports the body’s own processes to heal and regenerate. Because
no disease-transfer risk exists between cold-water fish and humans,
the Kerecis fish skin is only gently processed and retains its
similarity to human tissue. The gentle processing preserves the
skin’s original three-dimensional structure, maintaining its
inherent natural strength, complexity and molecules (such as fatty
acids). Clinical studies have found that the Kerecis products heal
wounds faster than competing products and are found cost effective.
Kerecis is the only approved manufacturer of medical devices
containing intact fish skin globally.
Kerecis is the fastest-growing and one of the top five companies
in the U.S. biologics-skin and dermal-substitute market, according
to SmartTRAK Business Intelligence. Kerecis’ expanding product
portfolio includes SurgiBind®/SurgiClose®, which are used for
reconstructive surgery in hospital operating rooms; GraftGuide®,
which is mostly sold to burn centers; and MariGen® and Shield™,
which are sold to healthcare facilities to treat chronic wounds
such as diabetic wounds, as well as post-Moh's surgery wounds.
Kerecis is committed to the United Nations Sustainable
Development Goals. The fish skin used in Kerecis’ products derives
from wild and sustainable fish stock caught in pristine Icelandic
waters and processed with 100% renewable energy in the town of
Isafjordur, close to the Arctic Circle. Kerecis is part of
Coloplast, the leading global supplier of intimate healthcare
products. For more information, visit https://www.kerecis.com.
Trademarks and registered trademarks are the property of their
respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501756159/en/
Kay Paumier Communications Plus kay@communicationsplus.net
408-370-1243 (office) 408-806-1177 (mobile)